The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Annual lung cancer screening by chest x-ray results in higher profits for the exclusion of lung cancer.
 
Tatsuo Kimura
No Relationships to Disclose
 
Shinya Fukumoto
Speakers' Bureau - Astellas Pharma; Mitsubishi Tanabe Pharma; Novo Nordisk; Sanofi; Takeda
Research Funding - Taisho Pharmaceutical Holdings
 
Hiroyasu Morikawa
No Relationships to Disclose
 
Akemi Nakano
No Relationships to Disclose
 
Koji Otani
No Relationships to Disclose
 
Yukie Tauchi
No Relationships to Disclose
 
Risa Uemura
No Relationships to Disclose
 
Tomohiro Suzumura
No Relationships to Disclose
 
Koichi Ogawa
No Relationships to Disclose
 
Tomoya Kawaguchi
Honoraria - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Lilly Japan (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Norifumi Kawada
No Relationships to Disclose